After just 21 days, Medowie Build for a Cure house is unveiled

Television personality Scott Cam, Knights captain Mitchell Pearce and former Block contestants Maxine and Karstan mixed with interested buyers on Sunday at the unveiling of the Build for a Cure home in Medowie.

Representatives from the Children’s Cancer Institute, builders McDonald Jones Homes, McCloy Group and Austral Bricks who had joined together to achieve the extraordinary challenge of building the entire house in just 21 days also attended the reveal day on Sunday.

Every inch of the house – including the land, materials, labour and furnishings – was generously donated from a suite of corporate partners and community groups. 

The four-bedroom house, situated in The Bower estate at Medowie, will be auctioned onsite on October 21. It is expected to fetch somewhere in the vicinity of $650,000.

Mr Cam, a Build for a Cure ambassador, said he was excited to attend the reveal day.

“It’s not every day you see an entire house built in just 21 days. It’s remarkable to see the hundreds of volunteer that work together to make this happen,” Cam said.

“The Build for a Cure home is the ultimate package. It’s a masterfully-built home, finished with professional interior design, immaculate landscaping and high-quality appliances all set in the beautiful Bower estate at Medowie.”

Rain could not deter the enthusiasm of builders who began construction at the new Bower estate on August 27.

Rain could not deter the enthusiasm of builders who began construction at the new Bower estate on August 27.

Originally founded by two fathers of children with cancer in 1976, The Children’s Cancer Institute is the only independent medical research institute in Australia wholly dedicated to research into the causes, prevention and cure of childhood cancer.

Forty years on, the vision remains unchanged – to save the lives of all children with cancer and to eliminate their suffering.

The institute has grown to now employ more than 200 researchers, operational staff and students, and has established a national and international reputation for scientific excellence.

A Children’s Cancer Institute spokesperson said that the focus remained on translational research.

“We have an integrated team of laboratory researchers and clinician scientists who work together in partnership to discover new treatments which can be progressed from the lab bench to the beds of children on wards in our hospitals as quickly as possible,” the spokesperson said.

“These new treatments are specifically targeting childhood cancers, so we can develop safer and more effective drugs and drug combinations that will minimise side-effects and ultimately give children with cancer the best chance of a cure with the highest possible quality of life.

“We are currently leading the establishment of the Zero Childhood Cancer national child cancer personalised medicine program for children with the most aggressive cancers, in partnership with the Sydney Children’s Hospitals Network.

“This program will revolutionise the way treatment decisions are made, with the aim of improving survivorship for those children at highest risk of treatment failure from their disease.”